The Johns Hopkins Center for Immunization Research is looking for healthy volunteers to participate in an outpatient BCG vaccine study. If you are a healthy adult age 18-65, you may be eligible to ...

The BCG vaccine isn’t a COVID-19 vaccine per se, but it’s theorized that it could assist medical professionals in fighting the disease. And it’s healthcare workers who are getting the shot ...

BCG, or Bacillus Calmette-Guérin, is a cheap and safe vaccine that was first developed in the 1920s as a defense against tuberculosis (TB) – a bacterial lung infection.

The 102-year-old tuberculosis vaccine shrank liver cancer tumors in mice, which suggests it may be replicated in a human trial. If this was the case, the vaccine might prove successful in tackling ...

The BCG vaccine was developed to protect against tuberculosis, which is also known as TB. It was launched in 1921 and is typically administered to adults aged 16 to 35 who might be at risk of TB ...

The BCG vaccine, an vaccine originally made against tuberculosis, has a general stimulating effect on the immune system and is therefore effective against multiple infectious diseases - possibly ...

More than 100 years old, the BCG vaccine is used in many countries, not including the United States, and has been associated with reduced overall mortality rates in infants and children.

BCG, a century-old vaccine for tuberculosis, is in the news, raising hopes for the COVID-19 pandemic. But existing ecological studies have serious limitations. Randomized trials are urgently needed.

Clinical trials of the Bacille Calmette-Guerin (BCG) vaccine, which was first developed in the early 1920s, are planned in Europe and Australia to see if it can help reduce the prevalence and ...

While hopeful that the BCG vaccine will prove to be effective against Covid-19 – as with any of the treatments and vaccines under development – Dr. William Schaffner, an infectious disease ...